Related Experiment Video
Updated: Jul 29, 2025
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Spontaneous Prostatic Hemorrhage in a COVID-19 Patient: A Case Report
Jiaguo Huang1, Hongxiang Ding1, Chao Feng2
1Department of Urology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, People's Republic of China.
Insights
This study reports a rare case of severe macroscopic hematuria and significant hemoglobin drop in a COVID-19 patient due to spontaneous prostatic hemorrhage. Effective treatment involved electrocoagulation, plasma infusion, and medication, leading to full recovery.
Area of Science:
- Nephrology
- Infectious Diseases
- Urology
Background:
- Hematuria is a known complication of acute kidney injury in COVID-19 patients.
- Severe macroscopic hematuria leading to hemoglobin decline in COVID-19 has not been previously documented.
Abstract:
Hematuria occurring in patients with acute kidney injury caused by Corona Virus Disease 2019 (COVID-19) infection has been reported. However, cases of macroscopic hematuria in COVID-19 patients leading to a severe decrease in hemoglobin have not been reported heretofore. Herein, we describe the case of a 56-year-old male patient who suffered from spontaneous prostatic hemorrhage caused by thrombocytopenia and coagulation dysfunction associated with COVID-19 infection, which manifested as macroscopic hematuria, bladder blood clot tamponade and severe hemoglobin decline. Prostatic hemorrhage was diagnosed by endoscopy. There was no recurrence of macroscopic hematuria after undergoing transurethral prostate electrocoagulation for hemostasis, infusing plasma to supplement coagulation factors and taking finasteride. One month after the bleeding event, the patient's blood routine reexamination revealed that the platelet count returned to the normal value and coagulation was normal.
